How to invest $10,000 in ASX 200 shares today

Find out why I think CSL Limited (ASX: CSL) and one other ASX 200 share could be a great way to invest $10,000 in the current market.

ASX 200 shares have had a rocky start to the year. The S&P/ASX 200 Index (ASX: XJO) is down 16.17% in 2020 with the coronavirus pandemic and an oil price war hitting share prices hard.

However, we could be at a turning point in global markets. OPEC+ have slashed their daily oil production by around 10%, while US markets stormed higher overnight on the back of optimism surrounding a possible conronavirus vaccine.

So, what's a good way to invest some spare cash in the market right now?

How to invest $10,000 in ASX 200 shares today

I think it's important to invest in high-quality companies for the long-term. However, I get that it's not easy to just ignore all the short-term share price movements in the meantime. 

I believe CSL Limited (ASX: CSL) could be a smart, long-term choice for investing $10,000 today. It's the largest ASX 200 share by market capitalisation and is worth $139 billion right now. The biotech giant is looking to develop a potentially lifesaving plasma-derived treatment for people with COVID-19. Other than these short-term efforts, I also think CSL has a great business model overall.

It's a leader in blood plasma treatment and biotechnology with a strong business moat. The CSL share price is trading at over $300 per share which is a testament to its long-term success since listing in 1994 at a stock-split-adjusted $0.766 per share. It's hard to bet against the ASX 200 healthcare share given its track record and strong research and development pipeline.

CSL aside, I also like another Aussie large-cap share right now. Commonwealth Bank of Australia (ASX: CBA) shares have crashed lower in 2020 with investors selling off ASX bank shares in droves. 

The CBA share price is down 24.97% since the start of the year thanks to the COVID-19 shutdown. There are fears for what the economic impact of the pandemic will be for Aussie businesses and their lenders. We've seen ASX 200 bank shares fall after announcing billions of dollars of impairments this year despite unprecedented government stimulus measures.

However, I think the CBA share price could be another way to successfully invest $10,000 today. The bank is a key pillar of the Aussie economy and could emerge with a refined business model and strong risk measures. This means CBA could be a leaner, stronger ASX 200 bank share that can churn out consistent profits in the decades ahead.

Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

Could this ASX biotech really jump more than 80% in value?

This company's new technology has one broker impressed.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

CSL vs Pro Medicus: Which ASX healthcare share is better?

Both CSL and Pro Medicus have faced recent challenges but have enviable long-term track records. Here's which one I'd buy…

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

This ASX biotech could rise almost 50%, Morgans says

Turning science into contracts could unlock value for this company.

Read more »

Doctor with stethoscope using a tablet in a hospital.
Healthcare Shares

Telix Pharmaceuticals wins FDA Fast Track for BiPASS prostate cancer imaging

Telix Pharmaceuticals shares are in the spotlight after the FDA granted Fast Track for its BiPASS pre-biopsy prostate cancer imaging…

Read more »

Three scientists looking at a laptop in a lab.
Healthcare Shares

What would it take for CSL shares to return to $250?

The shares have already recovered strongly, so I wanted to see whether $250 is realistic.

Read more »

Doctor with stethoscope typing on her computer.
Healthcare Shares

Is the ResMed share price a cheap buy?

I look at what the next few years of earnings growth could mean for today’s valuation.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Expert names 'undervalued' ASX 200 healthcare stock to buy today

A top fundie expects more outperformance from this resurgent ASX healthcare share.

Read more »

A gavel is placed on a stand on a desk with a legal representative wearing a suit in the background.
Healthcare Shares

Cochlear shares fall as investors face another setback

Cochlear shares are back in the red.

Read more »